These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 7991219)
1. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Ehrich M; Correll L; Veronesi B Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219 [TBL] [Abstract][Full Text] [Related]
2. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE). Sogorb MA; González-González I; Pamies D; Vilanova E Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283 [TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Ehrich M; Correll L; Veronesi B Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by organophosphorus esters. Ehrich M; Correll L J Toxicol Environ Health A; 1998 Mar; 53(5):385-99. PubMed ID: 9515941 [TBL] [Abstract][Full Text] [Related]
6. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate. Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135 [TBL] [Abstract][Full Text] [Related]
7. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135 [TBL] [Abstract][Full Text] [Related]
8. Modification of mipafox-induced inhibition of neuropathy target esterase in neuroblastoma cells of human origin. Nostrandt AC; Ehrich M Toxicol Appl Pharmacol; 1993 Jul; 121(1):36-42. PubMed ID: 8337699 [TBL] [Abstract][Full Text] [Related]
9. QSAR for the organophosphate-induced inhibition and 'aging' of the enzyme neuropathy target esterase (NTE). Singh AK SAR QSAR Environ Res; 2001; 12(3):275-95. PubMed ID: 11696925 [TBL] [Abstract][Full Text] [Related]
10. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Wu SY; Casida JE Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903 [TBL] [Abstract][Full Text] [Related]
11. Esterase inhibition in SH-SY5Y human neuroblastoma cells following exposure to organophosphorus compounds for 28 days. Barber DS; Ehrich M In Vitr Mol Toxicol; 2001; 14(2):129-35. PubMed ID: 11690566 [TBL] [Abstract][Full Text] [Related]
12. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998 [TBL] [Abstract][Full Text] [Related]
13. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon. Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916 [TBL] [Abstract][Full Text] [Related]
14. Using neuroblastoma cell lines to address differential specificity to organophosphates. Ehrich M Clin Exp Pharmacol Physiol; 1995 Apr; 22(4):291-2. PubMed ID: 7671443 [TBL] [Abstract][Full Text] [Related]
15. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Pope CN; Tanaka D; Padilla S Chem Biol Interact; 1993 Jun; 87(1-3):395-406. PubMed ID: 8343996 [TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates. Malygin VV; Sokolov VB; Richardson RJ; Makhaeva GF J Toxicol Environ Health A; 2003 Apr; 66(7):611-25. PubMed ID: 12746136 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the neurotoxic effects of neuropathic organophosphorus compounds in adult zebrafish. Faria M; Fuertes I; Prats E; Abad JL; Padrós F; Gomez-Canela C; Casas J; Estevez J; Vilanova E; Piña B; Raldúa D Sci Rep; 2018 Mar; 8(1):4844. PubMed ID: 29555973 [TBL] [Abstract][Full Text] [Related]
18. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094 [TBL] [Abstract][Full Text] [Related]
19. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Makhaeva GF; Malygin VV; Strakhova NN; Sigolaeva LV; Sokolovskaya LG; Eremenko AV; Kurochkin IN; Richardson RJ Hum Exp Toxicol; 2007 Apr; 26(4):273-82. PubMed ID: 17615108 [TBL] [Abstract][Full Text] [Related]
20. Species susceptibility to delayed toxic neuropathy in relation to in vivo inhibition of neurotoxic esterase by neurotoxic organophosphorus esters. Soliman SA; Linder R; Farmer J; Curley A J Toxicol Environ Health; 1982 Feb; 9(2):189-97. PubMed ID: 7077681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]